Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Share Your Story: Help Shape the Future of Noncompete Agreements for Rheumatologists

From the College  |  September 20, 2025

On Sept. 4, the Federal Trade Commission (FTC) released a Request for Information (RFI) asking for input from stakeholders on how noncompete agreements are used, how common they are, what kinds of workers are bound by them and the kinds of restrictions they often impose (e.g. duration, geography, roles). The RFI also asks for information on how these agreements impact job mobility, wages and hiring challenges, such as for employers trying to hire people bound elsewhere.

Due to the specificity and tone of the questions, ACR members are encouraged to respond to the RFI and give their personal experience about how noncompete agreements have impacted them. Instructions for responding confidentially are given in the RFI. The deadline for responding is Nov. 3.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The RFI comes on the heels of the FTC withdrawing its appeals in Ryan, LLC v. FTC and Properties of the Villages v. FTC, both of which ruled that the FTC overstepped its rulemaking authority when it banned most noncompete agreements in 2024. The ACR strongly supported the 2024 rule. However, with a broad rule off the table for now, the FTC has signaled it plans to enforce the law against noncompete agreements in specific instances where it views them as unfair or anticompetitive.

In particular, the ACR is encouraged that the FTC has once again signaled that it is ramping up scrutiny of noncompete agreements, this time with a pointed message to healthcare employers and staffing firms. On Sept. 9, it issued formal warning letters to several large companies in the healthcare sector, urging them to review their use of noncompete clauses and other postemployment restrictions.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The RFI also signals the FTC’s intent to gather detailed data to identify where noncompete agreements are overused or harmful. This will help inform whether enforcement actions are justified in specific cases. Since the broad noncompete ban was rejected, the FTC seems to be favoring a case-by-case or sector-by-sector approach. Input gathered through the RFI may help the FTC decide where to focus its investigations.

The ACR is working to amplify the voices of rheumatologists nationwide through an opinion piece  to be placed in a major media outlet. Consider sharing how a noncompete agreement has negatively impacted your career and patients. Your compelling personal story and expert insights could help inform the public and policymakers. We will guide you through the process, help you craft your message and ensure your story includes a clear call to action. It requires minimal time commitment. To get involved or for further information about the ACR’s regulatory advocacy efforts, email the ACR’s advocacy team at [email protected].

ACR/ARP members can also schedule a time to meet directly with the ACR’s advocacy team to discuss issues and challenges you are facing.

Share: 

Filed under:Legislation & AdvocacyProfessional TopicsWorkforce Tagged with:noncompete agreements

Related Articles

    FTC Bans Noncompete Agreements: What Rheumatologists Need to Know

    May 5, 2024

    The ACR applauds the FTC’s recent ban on most noncompete agreements. The ruling is a step in the right direction toward a more competitive market for healthcare workers and their services.

    Status Check: Non-Compete Agreements in Healthcare

    October 7, 2024

    The FTC issued a Final Rule that banned non-compete agreements, but the rule was recently halted by a nationwide injunction from a federal court in Texas. 

    Federal Regulatory Actions Against Healthcare Consolidation

    June 8, 2024

    In recent months, the U.S. Department of Justice and Federal Trade Commission have started to take action to rein in antitrust behavior, including banning noncompete agreements in the for-profit sector and establishing a taskforce on healthcare monopolies.

    Florida Law Puts Drug Pricing by Pharmacy Benefit Managers Under a Microscope Once Again

    August 8, 2022

    As of July 1, a Florida bill increases oversight of pharmacy benefit managers and offers some protection for pharmacies. However, the legislation has limited effects on patients and providers, highlighting the need for additional reform.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences